Related references
Note: Only part of the references are listed.Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations
Robert H. Dworkin et al.
JOURNAL OF PAIN (2008)
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Robert H. Dworkin et al.
PAIN (2007)
Neuronal nicotinic receptors: A perspective on two decades of drug discovery research
Stephen P. Arneric et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Emerging drugs in neuropathic pain
Ian Gilron et al.
EXPERT OPINION ON EMERGING DRUGS (2007)
EFNS guidelines on pharmacological treatment of neuropathic pain
N. Attal et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Neuronal nicotinic acetylcholine receptors as a target for the treatment of neuropathic pain
Michael D. Meyer
DRUG DEVELOPMENT RESEARCH (2006)
Duloxetine vs. placebo in patients with painful diabetic neuropathy
DJ Goldstein et al.
PAIN (2005)
Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens
R Freynhagen et al.
PAIN (2005)
Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial
RW Richter et al.
JOURNAL OF PAIN (2005)
Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial
J Rosenstock et al.
PAIN (2004)
Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications
MR Picciotto et al.
PHARMACOLOGY & THERAPEUTICS (2001)
ABT-594 -: Treatment of neuropathic pain -: Nicotinic agonist
LA Sorbera et al.
DRUGS OF THE FUTURE (2001)
The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control
MW Decker et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2001)
Share Paper
